Tech Company Financing Transactions
Vizgen Funding Round
On 4/8/2021, Vizgen secured $37 million in Series B funding from Northpond Ventures, Novalis LifeSciences and Arch Venture Partners.
Transaction Overview
Company Name
Announced On
4/8/2021
Transaction Type
Venture Equity
Amount
$37,000,000
Round
Series B
Investors
Northpond Ventures (Lead Investor)
Novalis LifeSciences (Lead Investor)
private investors (David Walt)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
37 Spinelli Pl.
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Undisclosed
Website
Email Address
Overview
Vizgen is unlocking the power of spatial biomolecule profiling to bring new insight into biological systems and disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Terry Lo
Chief Financial Officer
Philip Gardella
Co-Founder
George Emanuel
Co-Founder
Jiang He
VP - Engineering
Peidong Wang
Browse more venture capital transactions:
Prev: 4/8/2021: Nuvocargo venture capital transaction
Next: 4/8/2021: Mickey venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs